Bardet, who finished third behind Froome at the Tour de France in July, said that the news that the Team Sky rider had twice the permitted level of asthma drug salbutamol in his urine after stage 18 of the Vuelta a España had an impact on everyone in the sport.
"This is not good news for cycling. Pretty much everyone gets hit by something like this, cycling's credibility first and foremost," Bardet told AFP (opens in new tab).
"We really could have done without it. It's not something anyone can rejoice about. Let's hope that a swift and objective probe can clarify the facts and leave no doubts about what happened."
As the World Anti-Doping classifies salbutamol as a specified substance, Froome has not been given a provisional suspension. However in line with the UCI's anti-doping procedure, Froome's case will now be referred to the Legal Anti-Doping Services (LADS), with the rider and Team Sky being required to explain the elevated levels of salbutamol in Froome's system.
Riders have previously received sanctions for delivering high levels of salbutamol, with Diego Ulissi receiving a nine-month ban in 2014, and Alessandro Petacchi being banned for a year in 2007. However other riders have been cleared for medical reasons.
In a statement issued as news of Froome's AAF emerged on Wednesday, Team Sky said that it would be looking at a range of factors to explain the high levels of salbutamol in Froome's urine, with the aim of having its rider cleared through a pharmacokinetic study.
"There is considerable evidence to show that there are significant and unpredictable variations in the way salbutamol is metabolised and excreted.
"As a result, the use of permissible dosages of salbutamol can sometimes result in elevated urinary concentrations, which require explanation. A wide range of factors can affect the concentrations, including the interaction of salbutamol with food or other medications, dehydration and the timing of salbutamol usage before the test."
Froome himself has also denied any wrongdoing, saying that he will comply fully with the UCI's investigation.
"It is well known that I have asthma and I know exactly what the rules are. I use an inhaler to manage my symptoms (always within the permissible limits) and I know for sure that I will be tested every day I wear the race leader’s jersey," the 32-year-old said.
"My asthma got worse at the Vuelta so I followed the team doctor’s advice to increase my salbutamol dosage. As always, I took the greatest care to ensure that I did not use more than the permissible dose.
"I take my leadership position in my sport very seriously. The UCI is absolutely right to examine test results and, together with the team, I will provide whatever information it requires."
Thank you for reading 5 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Henry Robertshaw began his time at Cycling Weekly working with the tech team, writing reviews, buying guides and appearing in videos advising on how to dress for the seasons. He later moved over to the news team, where his work focused on the professional peloton as well as legislation and provision for cycling. He's since moved his career in a new direction, with a role at the Department for Environment, Food and Rural Affairs.
Enric Mas drops Tadej Pogačar to prevail in Giro dell’Emilia
Elisa Longo Borghini won the women’s edition of the race earlier in the day
By Tom Davidson • Published
Nairo Quintana to leave Arkéa-Samsic, six weeks after signing new contract
The Colombian is currently appealing his Tour de France disqualification
By Tom Davidson • Published
Chris Froome out of Tour de France after positive Covid-19 test result
Four-time winner and third on Alpe d’Huez stage forced to abandon on stage 18
By Tom Thewlis • Published
'I’m going to keep pushing. I don’t know what my limits are': Chris Froome climbs to best result since 2018
Israel-Premier Tech rider finished third on stage 12 of the Tour de France to Alpe d'Huez
By Adam Becket • Published